Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Mizuna Sekine

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
corporate, debt facility, healthcare and life sciences
Office
Not stated
Active in the record
2023 to 2025

Deal experience

Deal types
Banking & FinanceCapital Markets & IPODebt Capital MarketsM&AVenture Capital & Growth
Sectors
Healthcare & Life Sciences
Jurisdictions
United KingdomUnited States

Recent deals

11 announced deals in the record
Latham & Watkins Advises Chugai Pharmaceutical in US$1.085 Billion License Agreement With Rani Therapeutics 23 Oct 2025
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 1.08bn corporate
Latham & Watkins Advises Hazel Health in Acquisition of Little Otter 17 Oct 2025
M&A Healthcare & Life Sciences Latham & Watkins LLP intellectual property
Latham & Watkins Advises Coherus BioSciences in US$558.4 Million Divesture of UDENYCA Franchise to Intas Pharmaceuticals 5 Dec 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 558m intellectual property
Latham & Watkins Advises PROCEPT BioRobotics on Offering of Common Stock 3 Nov 2024
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 175m IP
Latham & Watkins Advises Ascendis Pharma in US$150 Million Royalty Financing 9 Sept 2024
Debt Capital Markets Healthcare & Life Sciences Latham & Watkins LLP USD 150m intellectual property
Latham & Watkins Advises Arcus Biosciences in US$250 Million Growth Facility 31 Aug 2024
Banking & Finance Healthcare & Life Sciences Latham & Watkins LLP USD 250m intellectual property
Latham & Watkins Advises scPharmaceuticals on Growth Financings 13 Aug 2024
Banking & Finance Healthcare & Life Sciences Latham & Watkins LLP USD 125m healthcare and life sciences
Latham & Watkins Advises Seres Therapeutics in VOWST Asset Purchase Agreement With Nestlé Health Science 7 Aug 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP licensing and intellectual property
Latham Advises Coherus BioSciences in US$40 Million Divestment 28 Jun 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 40m healthcare and life sciences
Latham & Watkins Advises Verona Pharma in US$650 Million Strategic Financing, One of the Largest Life Sciences Financings of 2024 16 May 2024
Banking & Finance Healthcare & Life Sciences Latham & Watkins LLP USD 650m debt facility
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when Mizuna Sekine is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 11 deals for Mizuna Sekine

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction